Hubei Jumpcan (China) Today
| 600566 Stock | 29.02 0.12 0.42% |
Performance0 of 100
| Odds Of DistressLess than 1
|
Hubei Jumpcan is trading at 29.02 as of the 28th of November 2024, a 0.42 percent increase since the beginning of the trading day. The stock's open price was 28.9. Hubei Jumpcan has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Hubei Jumpcan Pharmaceutical are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of September 2024 and ending today, the 28th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 1st of August 2001 | Category Healthcare | Classification Health Care |
Hubei Jumpcan is entity of China. It is traded as Stock on SHG exchange. The company has 921.7 M outstanding shares. More on Hubei Jumpcan Pharmaceutical
Moving together with Hubei Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Hubei Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Hubei Jumpcan's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Hubei Jumpcan or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Vice Chairman | Qu Huang | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) | ||||
Hubei Jumpcan's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Hubei Jumpcan's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsHubei Jumpcan can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Hubei Jumpcan's financial leverage. It provides some insight into what part of Hubei Jumpcan's total assets is financed by creditors.
| |||||
Hubei Jumpcan Pharmaceutical (600566) is traded on Shanghai Stock Exchange in China and employs 5,230 people. Hubei Jumpcan is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 26.46 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Hubei Jumpcan's market, we take the total number of its shares issued and multiply it by Hubei Jumpcan's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Hubei Jumpcan Pharma operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 921.7 M outstanding shares.
Hubei Jumpcan generates positive cash flow from operations, but has no cash available
Check Hubei Jumpcan Probability Of Bankruptcy
Ownership AllocationHubei Jumpcan Pharmaceutical has a total of 921.7 Million outstanding shares. Hubei Jumpcan retains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 62.47 (percent) of Hubei Jumpcan outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Hubei Ownership Details
Hubei Jumpcan Pharma Risk Profiles
Although Hubei Jumpcan's alpha and beta are two of the key measurements used to evaluate Hubei Jumpcan's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.08 | |||
| Standard Deviation | 3.12 | |||
| Variance | 9.71 | |||
| Risk Adjusted Performance | (0.04) |
Hubei Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Hubei Jumpcan without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Price Transformation Now
Price TransformationUse Price Transformation models to analyze the depth of different equity instruments across global markets |
| All Next | Launch Module |
Other Information on Investing in Hubei Stock
Hubei Jumpcan financial ratios help investors to determine whether Hubei Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hubei with respect to the benefits of owning Hubei Jumpcan security.